Who to call at Organon & Co., and when
Fundz watches for the moments Organon & Co. starts buying, and tells you who to reach.
- An alert the day Organon & Co. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Organon & Co., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Organon & Co.. With Fundz connected, it knows.
Organon & Co.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
www.organon.com2 executive changes at Organon in the last 90 days. Clusters like this usually mean more senior seats open over the next few months.
The seat is still open. No replacement has been named 364 days after this filing.
See every company with multiple executive changes →AI Executive Summary
AI-powered analysis of 8-K filing content
Organon & Co. CEO Kevin Ali resigned as CEO and from the Board on October 26, 2025, in connection with an ongoing investigation, and waived severance and equity-related retirement benefits. Joseph Morrissey, the company's EVP and Head of Manufacturing & Supply, was named Interim CEO and Carrie S. Cox was appointed Executive Chair for an interim period.
Key Takeaways
CEO Kevin Ali resigned from the CEO role and the Board on October 26, 2025, in connection with an investigation referred to in Item 8.01 of the filing. The filing does not describe the investigation's
Ali agreed he will not receive severance or equity-related retirement benefits tied to his resignation.
3 more takeaways
Filing Overview
What This Means
Organon & Co. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.